IP Library Granted Patent US 11,273,316
Granted Patent B2
US 11,273,316 · App. 16/556,701 · Granted Mar 15, 2022

Redundant traces for flexible circuits used in an energy delivery device

Inventors: Craig Collins (Woodinville, WA); Kurt Duclos (Kenmore, WA); Martin Kenney (Bothell, WA)
Assignee: BAUSCH HEALTH IRELAND LIMITED
A61N1/40G01K7/24H05K1/0277H05K1/189H05K2201/10151H05K2201/10196
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,273,316
App. No.
16/556,701
Granted
Mar 15, 2022
Kind
B2
Abstract

Energy delivery devices with a flexible circuit. The energy delivery devices may be used in the treatment of human tissue, and the flexible circuit move or flex during use. The flexible circuit may include an electronic component and a trace connected with the electronic component. The trace may have a plurality of sections that provide parallel current paths over a portion of the trace. Alternatively, the flexible circuit may include a plurality of traces that are connected with the terminal of the electronic component to provide parallel current paths over their entire length to the terminal of the electronic component. These redundant parallel current paths improve device reliability.

Claims (18)

1. An apparatus comprising:

an energy delivery device including a flexible circuit, the flexible circuit including an electronic component and a first trace connected with the electronic component, the first trace having a plurality of sections that provide a first set of parallel current paths over a portion of the first trace,

wherein the plurality of sections of the first trace comprise a first section and a second section, and the portion of the first trace is split into the first section and the second section by a slit.

2. The apparatus of claim 1 wherein the electronic component is a temperature sensor, and the first trace is connected with the temperature sensor.

3. The apparatus of claim 2 wherein the temperature sensor is a thermistor.

4. The apparatus of claim 1 wherein the electronic component includes a first terminal and a second terminal, the first trace is connected to the first terminal of the electronic component, the flexible circuit includes a second trace connected to the second terminal of the electronic component, and the second trace has a plurality of sections that provide a second set of parallel current paths over a portion of the second trace.

5. The apparatus of claim 1 further comprising:

a support member,

wherein the flexible circuit is folded about a surface of the support member along a fold line, and each section of the first trace extends along a respective longitudinal axis that crosses the fold line.

6. The apparatus of claim 5 wherein the longitudinal axis of each section of the first trace is oriented transverse to the fold line.

7. The apparatus of claim 4 wherein the plurality of sections of the second trace comprise a first section and a second section, and the portion of the second trace is split into the first section and the second section by a slit.

8. The apparatus of claim 1 wherein the energy delivery device is included in a treatment tip that is configured to be detachably coupled with a handpiece.

9. The apparatus of claim 1 wherein the flexible circuit includes a treatment electrode configured to emit high frequency electromagnetic energy in the radio-frequency band of the electromagnetic spectrum, and the first trace is connected with the treatment electrode.

10. An apparatus comprising:

an energy delivery device including a flexible circuit, the flexible circuit including an electronic component and a first trace connected with the electronic component, the first trace having a plurality of sections that provide a first set of parallel current paths over a portion of the first trace,

wherein the electronic component includes a first terminal and a second terminal, the first trace is connected to the first terminal of the electronic component, the flexible circuit includes a second trace connected to the second terminal of the electronic component, and the second trace has a plurality of sections that provide a second set of parallel current paths over a portion of the second trace, and

wherein the plurality of sections of the second trace comprise a first section and a second section, and the portion of the second trace is split into the first section and the second section by a slit.

11. The apparatus of claim 10 wherein the plurality of sections of the first trace comprise a first section and a second section, and the portion of the first trace is split into the first section and the second section by a slit.

Assignments (12)
U.S. PATENT SECURITY AGREEMENT Recorded Nov 25, 2025
From: SOLTA MEDICAL IRELAND LIMITED
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 073715/0394 →
RELEASE OF SECURITY INTEREST Recorded Nov 20, 2025
From: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
To: BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH, CANADA INC.; BAUSCH HEALTH IRELAND LIMITED; SOLTA MEDICAL IRELAND LIMITED
Reel/Frame 073654/0300 →
RELEASE OF SECURITY INTEREST Recorded Apr 8, 2025
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: SOLTA MEDICAL, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED); SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD; SANTARUS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; HUMAX PHARMACEUTICAL S.A.; SOLTA MEDICAL IRELAND LIMITED; BAUSCH & LOMB MEXICO, S.A. DE C.V.; BAUSCH+LOMB OPS B.V.; BAUSCH HEALTH AMERICAS, INC.; BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH HOLDCO LIMITED; BAUSCH HEALTH MAGYARORSZAG KFT (A/K/A BAUSCH HEALTH HUNGARY LLC); BAUSCH HEALTH POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA (F/K/A VALEANT PHARMA POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA); BAUSCH HEALTH US, LLC; BAUSCH HEALTH, CANADA INC. / SANTE BAUSCH, CANADA INC.; ICN POLFA RZESZOW SPOLKA AKCYJNA (A/K/A ICN POLFA RZESZOW S.A.); ORAPHARMA, INC.; PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA SPOLKA AKCYJNA (A/K/A PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA S.A.); SOLTA MEDICAL DUTCH HOLDINGS B.V.; V-BAC HOLDING CORP.; VRX HOLDCO LLC; 1261229 B.C. LTD.; 1530065 B.C. LTD.
Reel/Frame 070778/0199 →
CONFIRMATORY PATENTS ASSIGNMENT Recorded Jan 11, 2023
From: BAUSCH HEALTH IRELAND LIMITED
To: SOLTA MEDICAL IRELAND LIMITED
Reel/Frame 062352/0396 →
SECURITY AGREEMENT (FIRST LIEN) Recorded Nov 4, 2022
From: BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH IRELAND LIMITED; SOLTA MEDICAL IRELAND LIMITED
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 061882/0708 →
SECURITY AGREEMENT (SECOND LIEN) Recorded Nov 4, 2022
From: BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH IRELAND LIMITED; SOLTA MEDICAL IRELAND LIMITED
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 062078/0276 →
SECURITY AGREEMENT (SECOND LIEN) Recorded Oct 5, 2022
From: BAUSCH HEALTH US, LLC; BAUSCH HEALTH AMERICAS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; SOLTA MEDICAL, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 061606/0468 →
SECURITY AGREEMENT (FIRST LIEN) Recorded Oct 4, 2022
From: BAUSCH HEALTH US, LLC; BAUSCH HEALTH AMERICAS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; SOLTA MEDICAL, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 061595/0066 →
SECURITY INTEREST Recorded Jun 13, 2022
From: BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH, CANADA INC.; BAUSCH HEALTH IRELAND LIMITED; SOLTA MEDICAL IRELAND LIMITED
To: THE BANK OF NEW YORK MELLON
Reel/Frame 060346/0705 →
SECURITY INTEREST Recorded Oct 5, 2021
From: BAUSCH & LOMB IRELAND LIMITED; BAUSCH HEALTH COMPANIES INC.; DR. GERHARD MANN CHEM.-PHARM. FABRIK GMBH; TECHNOLAS PERFECT VISION GMBH
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 057821/0800 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Feb 4, 2020
From: BAUSCH HEALTH IRELAND LIMITED; BAUSCH & LOMB INCORPORATED; DOW PHARMACEUTICAL SCIENCES, INC.; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; BAUSCH HEALTH US, LLC; SANTARUS, INC.
To: THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT FOR THE NOTEHOLDER SECURED PARTIES
Reel/Frame 051797/0491 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Feb 4, 2020
From: BAUSCH HEALTH IRELAND LIMITED; BAUSCH & LOMB INCORPORATED; DOW PHARMACEUTICAL SCIENCES, INC.; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; BAUSCH HEALTH US, LLC; SANTARUS, INC.
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 051797/0416 →